✦ LIBER ✦

Maintenance Therapy With Low Dose Thalidomide, Dexamethasone and Clarithromycin (BLT-D) Following Autologous Transplant (ASCT) for Multiple Myeloma (MM)

✍ Scribed by L. Holmberg; T. Gooley; P. Becker; D. Maloney; W. Bensinger

Book ID: 116282239
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 50 KB
Volume: 17
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2010.12.297

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Maintenance Therapy With Low Dose Thalid

Maintenance Therapy With Low Dose Thalidomide, Dexamethasone, and Clarithromycin (BIAXIN) (BLT-D) Following Autologous Transplant (ASCT) for Multiple Myeloma (MM)

✍ L.A. Holmberg; W.I. Bensinger 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Maintenance Therapy With Lenalidomide, D

Maintenance Therapy With Lenalidomide, Dexamethasone and Clarithromycin (Bird) Following Autologous Transplant (ASCT) for Multiple Myeloma (MM)

✍ L. Holmberg; T. Gooley; P. Becker; W. Bensinger 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Pilot study of 13cis-retinoic acid+dexam

Pilot study of 13cis-retinoic acid+dexamethasone+alpha interferon as maintenance therapy following high-dose chemotherapy and autologous stem cell transplant for multiple myeloma

✍ Friedman, J; Khoury, H; Adkins, D; Devine, S; Nervi, B; Edwards, T; DiPersio, J; 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 140 KB

Post-transplant outcomes of induction th

Post-transplant outcomes of induction therapy for myeloma: Thalidomide and dexamethasone versus doxorubicin, vincristine, and dexamethasone prior to high-dose melphalan with autologous stem cell support

✍ Dan T. Vogl; Stephen V. Liu; Elise A. Chong; Selina M. Luger; David L. Porter; S 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB 👁 2 views

Sequential vincristine, adriamycin, dexa

Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: results of a phase II trial

✍ Hye Jin Kim; Sung-Soo Yoon; Dong Soon Lee; Sang Kyun Sohn; Hyeon Seok Eom; Jung 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 184 KB

A phase i/ii study of 166holmium-dotmp i

A phase i/ii study of 166holmium-dotmp in combination with high dose chemotherapy and autologous stem cell transplant(Asct) For the treatment of patients with multiple myeloma(Mm)

✍ W. Bensinger; S. Giralt; J. Eary; D. Podoloff; L. Holmberg; R. Alexanian; M. Goo 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 15 KB